While diabetes, chronic kidney disease (CKD), and cardiovascular disease are widely recognised, fewer people are aware of ๐ก๐ฒ๐ฉ๐๐ซ๐ค๐๐ฅ๐๐ฆ๐ข๐ (๐ก๐ข๐ ๐ก ๐ฉ๐จ๐ญ๐๐ฌ๐ฌ๐ข๐ฎ๐ฆ ๐ฅ๐๐ฏ๐๐ฅ๐ฌ), a serious condition that can occur alongside these diseases and increase the risk of life-threatening complications. That's why raising awareness and encouraging early screening are essential to helping more Malaysians understand their risks and seek timely care.
Today, together with AstraZeneca, we are proud to launch ๐๐ซ๐๐๐จ๐ฎ๐ซ๐๐ข๐๐ง๐๐ฒ๐ฌ๐๐+?, a kidney health awareness initiative dedicated to advancing early detection and improving awareness of cardio-kidney-metabolic (CKM) health.๐ค
Through this initiative, ๐๐,๐๐๐ ๐ฌ๐ฎ๐๐ฌ๐ข๐๐ข๐ฌ๐๐ ๐๐ฅ๐จ๐จ๐ ๐ญ๐๐ฌ๐ญ ๐ฌ๐๐ซ๐๐๐ง๐ข๐ง๐ ๐ฌ will be made available to support earlier risk detection through key health markers, including blood sugar, cholesterol, kidney function, and potassium levels. The programme is further complemented by a dedicated online hyperkalemia education platform and teleconsultation services, making trusted health information, professional guidance, and follow-up care more accessible than ever.
The launch also featured an expert panel discussion, "๐๐ข๐๐๐๐ญ๐๐ฌ ๐๐ข๐ฌ๐ค ๐ญ๐จ ๐๐ข๐๐ง๐๐ฒ ๐๐ซ๐จ๐ญ๐๐๐ญ๐ข๐จ๐ง: ๐๐ฎ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ข๐ง๐ ๐๐๐ซ๐ฅ๐ข๐๐ซ ๐๐๐๐จ๐ ๐ง๐ข๐ญ๐ข๐จ๐ง ๐จ๐ ๐๐ฒ๐ฉ๐๐ซ๐ค๐๐ฅ๐๐ฆ๐ข๐ ๐๐ข๐ฌ๐ค," where a nephrologist, an endocrinologist, and a pharmacist shared insights on multidisciplinary care, patient empowerment, and the importance of early intervention. Attendees also explored a series of interactive ๐ก๐ฒ๐ฉ๐๐ซ๐ค๐๐ฅ๐๐ฆ๐ข๐ ๐๐๐ฎ๐๐๐ญ๐ข๐จ๐ง๐๐ฅ ๐ฌ๐ญ๐๐ญ๐ข๐จ๐ง๐ฌ by AstraZeneca, offering engaging learning experiences that reinforced the importance of kidney health and early detection.
Because every screening is more than just a test, it is an opportunity to detect risks earlier, take action sooner, and protect your kidneys, your heart, and your future. ๐
